The Clorox Company (CLX)
After hours:
| Previous Close | 154.61 |
| Open | 155.66 |
| Bid | 157.35 x 800 |
| Ask | 157.70 x 1000 |
| Day's Range | 154.63 - 157.65 |
| 52 Week Range | 120.50 - 160.59 |
| Volume | |
| Avg. Volume | 1,180,809 |
| Market Cap | 19.455B |
| Beta (5Y Monthly) | 0.27 |
| PE Ratio (TTM) | 43.87 |
| EPS (TTM) | 3.59 |
| Earnings Date | May 01, 2023 - May 05, 2023 |
| Forward Dividend & Yield | 4.72 (3.05%) |
| Ex-Dividend Date | Apr 25, 2023 |
| 1y Target Est | 139.91 |
- Motley Fool
Best Dividend Stock: Coca-Cola vs. Walmart vs. eBay vs. Clorox
Coca-Cola (NYSE: KO), Walmart (NYSE: WMT), eBay (NASDAQ: EBAY), and Clorox (NYSE: CLX) all pay a solid dividend. Investors looking to generate passive income can do so with any of these dividend stocks.
- Motley Fool
These 3 Dividend Payers Are Outpacing the S&P 500
Investors have found some hidden gems in the midst of 2022's market meltdown, and are buying them back in a big way.
- Reuters
Clorox tries to sell loss-making vitamins business -sources
Bleach maker Clorox Co has been seeking to divest its vitamins, minerals and supplements (VMS) business after efforts to scale it led to major losses, according to four people familiar with the situation. The VMS business represents just 3% of Clorox's total net sales, yet in 2021 it forced it to take a $267 million writedown, equivalent to 57% of its most recent annual net earnings, as its vitamins and supplements lost market share to better known brands. Clorox has been working with investment bank Goldman Sachs Group Inc for several months to find a buyer for VMS but has so far failed to attract an offer it deems attractive, the sources said.
